Eczematous eruption after guselkumab treatment for psoriasisIL, interleukinTH, helper T cellTNF, tumor necrosis factoranti–interleukin-23eczemaeczematousguselkumabpsoriasisdoi:10.1016/j.jdcr.2019.09.005Birgit ReynTom HillaryAnn GilsJAAD Case Reports
Eczematous eruption associated with an elevated serum TARC level is a dermatological event associated with everolimus therapy. Everolimus, an inhibitor of the mammalian target of rapamycin, has been used in the treatment of several types of tumor. We report two cases of severe eczematous eruptions ...
Wilkinson SM, Smith AG, Davis MJ, et al. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis. 1992;51:881. ArticleCASPubMedPubMed CentralGoogle Scholar Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon alpha 2b and...
Dermatitis is an inflammation of the skin, often caused by an irritating substance or a contact allergy, which usually manifests as an itchy rash. Atopic dermatitis refers to a subgroup of inflammatory skin condition characterized by a chronic and relapsing course associated with epidermal barrier dy...
Given the increase in the widespread use of IVIg, we have shown that NB︰VB therapy is a candidate choice for the treatment of IVIg﹊nduced severe vesicular eczematous eruption.doi:10.1111/phpp.12666Rina KoizumiTakeshi FukumotoHaruki Jimbo
The eruption was treated with topical corticosteroids and emollient therapy. There was no other new drug administration or a history of irritants. There was no history of atopic diathesis except for one patient.Oral ivermectin is an effective therapy for the treatment of human scabies. A single ...
Dermatologists and primary care providers should collaborate to optimize treatment, particularly when polypharmacy is a factor. Further research is needed to improve the understanding of the mechanisms behind EDEs and to refine diagnostic strategies, thus minimizing patient morbidity.Joseph Gofman...
psoriatic patients treated with an anti IL-17A agent (secukinumab or ixekizumab).Methods: Retrospective analysis of a cohort of patients with chronic plaque psoriasis who started an anti IL-17A agent between September 2016-February 2019 and who developed cutaneous inflammatory eruptions during treatment...
selpercatinibThis study reports a 50-year-old patient presented with eczematous drug-eruption induced by selpercatinib after the treatment of non-small cell lung cancer (NSCLC). The patient has symmetric erythematous papules and plaques all over the body with dry, scaly ...
The objective of this report is to describe a case of eczematous skin eruption that occurred during letrozole treatment. A 61-year-old female patient was admitted with lump in the left breast. FNAC, HPE were done and the patient was diagnosed to have invasive ductal breast carcinoma. After a...